5PSQ-043 Nebulised voriconazole in lung transplant recipients: analysis of use, efficacy and tolerability

BACKGROUND: Fungal infection is a significant source of morbidity and mortality in lung-transplant recipients (LTR). To avoid systemic toxicity, various nebulised antifungal agents are used after transplant to prevent or treat invasive fungal infections (IFI). Nebulised liposomal amphotericin B (n-L...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Hosp Pharm
Main Authors: Mira, ML Ibarra, Perez, M Aguilar, Carreño, B Basagoiti, Guerrero, A Sanchez
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2018
Assuntos:
Section 5: Patient safety and quality assurance
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535448/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.397
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares